Guangzhou LBP Medicine Science & Technology Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Guangzhou LBP Medicine Science & Technology Co., Ltd. carries a market capitalization of 1.76B, placing it among publicly traded companies globally. Its enterprise value stands at 2.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.76B |
| Enterprise Value | 2.48B |
Share Statistics
Guangzhou LBP Medicine Science & Technology Co., Ltd. currently has 93.57M shares outstanding.
| Shares Outstanding | 93.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Guangzhou LBP Medicine Science & Technology Co., Ltd. trades at a trailing price-to-earnings ratio of 398.08. The price-to-sales ratio is 6.59, and the price-to-book ratio stands at 5.85.
| PE Ratio | 398.08 |
| PS Ratio | 6.59 |
| PB Ratio | 5.85 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | 208.66 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 6.16 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 189.19 |
Financial Position
Guangzhou LBP Medicine Science & Technology Co., Ltd. maintains a current ratio of 8.73, meaning it holds 8.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.44, indicating moderate leverage, while an interest coverage ratio of -23.87 demonstrates limited ability to service its debt obligations.
| Current Ratio | 8.73 |
| Quick Ratio | 2.17 |
| Debt / Equity | 1.44 |
| Debt / EBITDA | -1.24 |
| Interest Coverage | -23.87 |
Financial Efficiency
| Return on Equity (ROE) | -1.64 |
| Return on Assets (ROA) | -0.56 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 8.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.67 |
Taxes
Over the trailing twelve months, Guangzhou LBP Medicine Science & Technology Co., Ltd. has paid -5.81M in income taxes, reflecting an effective tax rate of 9.11.
| Income Tax | -5.81M |
| Effective Tax Rate | 9.11 |
Stock Price Statistics
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s stock has declined approximately -34.1958% over the past 52 weeks. The 50-day moving average sits at 21.86, while the 200-day moving average is 24.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.1958% |
| 50-Day Moving Average | 21.86 |
| 200-Day Moving Average | 24.78 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Guangzhou LBP Medicine Science & Technology Co., Ltd. generated 402.12M in revenue and converted that into -7.57M in net income, yielding earnings per share of -0.12. EBITDA reached -13.98M, while operating income came in at -13.98M.
| Revenue | 402.12M |
| Gross Profit | 256.22M |
| Operating Income | -13.98M |
| Pretax Income | -16.97M |
| Net Income | -7.57M |
| EBITDA | -13.98M |
| EBIT | -13.98M |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
Guangzhou LBP Medicine Science & Technology Co., Ltd. holds 164.70M in cash and equivalents against 17.36M in total debt, resulting in a net debt position of -40.80M. Total book value stands at 453.09M, with working capital of 586.47M providing operational flexibility.
| Cash & Cash Equivalents | 164.70M |
| Total Debt | 17.36M |
| Net Debt | -40.80M |
| Equity (Book Value) | 453.09M |
| Book Value Per Share | 4.91 |
| Working Capital | 586.47M |
Cash Flow
After subtracting -12.70M in capital expenditures, free cash flow totaled -12.70M - equivalent to -0.14 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -12.70M |
| Free Cash Flow | -12.70M |
| FCF Per Share | -0.14 |
Margins
Guangzhou LBP Medicine Science & Technology Co., Ltd. operates with a gross margin of 63.72, reflecting its pricing power and cost economics. The operating margin of -3.48 and net profit margin of -1.88 provide insight into operational efficiency.
| Gross Margin | 63.72 |
| Operating Margin | -3.48 |
| Pretax Margin | -4.22 |
| Profit Margin | -1.88 |
| EBITDA Margin | -3.48 |
Dividends & Yields
The company's payout ratio of -2.54 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | -2.54 |
| Shareholder Yield | 0.47 |
| FCF Yield | 0.48 |
Scores
Guangzhou LBP Medicine Science & Technology Co., Ltd. posts an Altman Z-Score of 14.41, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.41 |